Kamal Hezam
Overview
Explore the profile of Kamal Hezam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
You W, Garcia L, Hezam K, Rita Chang H
Arch Gerontol Geriatr
. 2024 Nov;
129:105691.
PMID: 39541749
Background: Biological aging is known to impact quality of life, but its precise role is debated. Objective: This study explores how biological aging, measured by life expectancy at birth (e0),...
2.
Saeed A, Shao H, Hezam K, Liu C, Zhang Q, Tang X
Front Neurol
. 2024 May;
15:1360091.
PMID: 38694782
Background: Low Back Pain (LBP) is a pervasive and complex musculoskeletal condition affecting over 80% of the global population. Lumbar Disc Degeneration (LDD) significantly contributes to LBP, and MRI is...
3.
Hezam K, Fu E, Zhang J, Li Z
Biochem Biophys Rep
. 2024 Apr;
38:101708.
PMID: 38623536
Mesenchymal stem cells (MSCs) have gained substantial attention in regenerative medicine due to their multilineage differentiation potential and immunomodulatory capabilities. MSCs have demonstrated therapeutic promise in numerous preclinical and clinical...
4.
Wang C, Hezam K, Fu E, Pan K, Liu Y, Li Z
Exp Cell Res
. 2024 Mar;
437(2):114013.
PMID: 38555014
Mesenchymal stem cells (MSCs) have been widely used to treat various inflammatory and immune-related diseases in preclinical and clinical settings. Intravital microscopy (IVM) is considered the gold standard for investigating...
5.
Al-Azab M, Idiiatullina E, Safi M, Hezam K
Biomed Pharmacother
. 2023 Apr;
162:114356.
PMID: 37040673
Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a range of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. Multiple preclinical investigations and clinical trials employed...
6.
Hezam K, Wang C, Fu E, Zhou M, Liu Y, Wang H, et al.
Stem Cell Res Ther
. 2023 Mar;
14(1):48.
PMID: 36949464
Background: Mesenchymal stem cells (MSCs) have demonstrated remarkable therapeutic promise for acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS). MSC secretomes contain various immunoregulatory mediators...
7.
Mubarik S, Wang F, Luo L, Hezam K, Yu C
Front Oncol
. 2023 Feb;
13:1101249.
PMID: 36845742
Background: Precise breast cancer-related mortality forecasts are required for public health program and healthcare service planning. A number of stochastic model-based approaches for predicting mortality have been developed. The trends...
8.
Jin Y, So H, Cerin E, Barnett A, Mubarik S, Hezam K, et al.
Front Nutr
. 2023 Jan;
9:1035439.
PMID: 36687675
Background And Aims: The disease burden attributable to metabolic risk factors is rapidly increasing in China, especially in older people. The objective of this study was to (i) estimate the...
9.
Al-Yousofi A, Yan Y, Al Mekhlafi A, Hezam K, Abouelnazar F, Al-Rateb B, et al.
J Trop Med
. 2022 Jun;
2022:5976640.
PMID: 35719317
Intestinal parasite infection (IPI) is still a very important public health issue. The severity of the parasitic disease has been reported as a high infection in immunocompromised patients and children....
10.
Kocarnik J, Compton K, Dean F, Fu W, Gaw B, Harvey J, et al.
JAMA Oncol
. 2021 Dec;
8(3):420-444.
PMID: 34967848
Importance: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing...